© 2026 Improve the News Foundation.
All rights reserved.
Version 8.2.1
Refusing to commit to restoring in-person dispensing rules for mifepristone cost this nomination, and rightly so. With an estimated 15,000 unborn babies dying monthly in pro-life states from mail-order abortion drugs, a rubber stamp at the FDA was never going to fly. Sen. Roger Marshall (R-Kan.), a pro-life OB-GYN already on the health committee, is the confirmable choice.
Sinking a qualified nominee for publicly affirming that the MMR vaccine is safe and effective shows how much vaccine loyalty tests now outrank science at the FDA. A nominee with a clear path to confirmation got dumped over an icy relationship with the MAHA crowd. Handing the agency to someone who questions vaccine safety would leave Americans less safe.
Overton's nomination deserved to fail. The FDA needs leadership committed to challenging Big Food and Big Pharma, not preserving the corporate status quo. Her resistance to investigating mRNA vaccine adverse events and efforts to derail scrutiny of ultra-processed foods made her the wrong choice. Trump's decision leaves the door open for a commissioner who puts public health ahead of industry interests.